Colotal tablets 135 mg инструкция на русском

Мебеверин-СЗ (Mebeverine-SZ) инструкция по применению

📜 Инструкция по применению Мебеверин-СЗ

💊 Состав препарата Мебеверин-СЗ

✅ Применение препарата Мебеверин-СЗ

📅 Условия хранения Мебеверин-СЗ

⏳ Срок годности Мебеверин-СЗ

Актуальная Гастроэнтерология от Северной Звезды

СЕВЕРНАЯ ЗВЕЗДА НАО
(Россия)

111524 Москва, ул. Электродная, д. 2, стр. 34, пом. 47 Тел./факс: +7 (495) 137-80-22 E-mail: electro@ns03.ru

Веремед
(ДЖОДАС ЭКСПОИМ, Россия)

Дюспаталин^®
(ABBOTT HEALTHCARE PRODUCTS, Нидерланды)

Дютан^®
(АЛИУМ, Россия)

Мебеверин
(ВЕЛФАРМ, Россия)

Мебеверин
(БИОКОМ, Россия)

Мебеверин-Вертекс
(ВЕРТЕКС, Россия)

Меберин МЛ
(MICRO LABS, Индия)

Мебеспалин
(АТОЛЛ, Россия)

Мебеспалин ретард
(АТОЛЛ, Россия)

Мебетан
(ФОРП, Россия)

• Производитель: PERRIGO ISRAEL PHARMACEUTICALS LTD
• Артикул: 32761
• Код ATX: A03AA04

Рекомендуемая цена в аптеках Израиля

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

MEBEVERINE HYDROCHLORIDE

Available from:

PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL

ATC code:

A03AA04

Pharmaceutical form:

TABLETS

Composition:

MEBEVERINE HYDROCHLORIDE 135 MG

Administration route:

PER OS

Prescription type:

Not required

Manufactured by:

PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL

Therapeutic group:

MEBEVERINE

Therapeutic area:

MEBEVERINE

Therapeutic indications:

Irritable bowel syndrome and conditions included in this group such as: Chronic irritable colon, Gastro- intestinal spasm secondary to organic diseases

Authorization date:

2023-08-31

Patient Information leaflet

                                PATIENT PACKAGE INSERT
ACCORDING TO PHARMACISTS’
REGULATIONS
)PREPARATIONS(- 1986
The medicine is dispensed
without a doctor’s prescription
COLOTAL TABLETS
135 MG
ACTIVE
INGREDIENT
AND
ITS
QUANTITY:
Each tablet contains 135 mg of
Mebeverine Hydrochloride.
Inactive ingredients and allergens
in the medicine - see in section 2
"
IMPORTANT
INFORMATION
ABOUT
SOME OF THE INGREDIENTS OF THIS
MEDICINE
" and in section 6 of this
leaflet.
READ THIS ENTIRE LEAFLET CAREFULLY
BEFORE
YOU
START
USING
THIS
MEDICINE. This leaflet contains
concise
information
about
the
medicine. If you have any further
questions,
ask
your
doctor
or
pharmacist. This medicine can be
sold without a doctor’s prescription.
However, the medicine should be
taken carefully to get the best
results from it. Keep this leaflet,
you may want to read it again.
Take the medicine according to the
dosage instructions in section 3 of
this leaflet. Consult a pharmacist
if you need additional information.
Refer to the doctor if the symptoms
worsen or do not improve after two
weeks.
1. WHAT IS THE MEDICINE
INTENDED FOR?
The medicine is intended to treat
spastic bowel syndrome )irritable
bowel syndrome(.
THERAPEUTIC GROUP:
Anticholinergics.
Irritable
bowel
syndrome
is
a
common
condition
that
causes
bowel spasms and pain. The bowel
is a long muscular tube that allows
the food to pass through it during
digestion. If the bowel contracts
too strongly, you will feel pain.
This medicine acts to relax the
contractions )spasms( and pain.
The main symptoms of irritable
bowel syndrome include:
• Stomach ache and spasms
• Feeling bloated and having gas
• Diarrhea
)with
or
without
constipation(
• Hard
and
small
pellet-like
or
ribbon-like stools
These symptoms may vary from
person to person. Tell your doctor
if you develop new symptoms or
if the symptoms continue more
than two weeks.
YOUR
DIET
AND
LIFESTYLE
CAN
ALSO HELP TREAT IRRITABLE BOWEL
SYNDROME: The way you restrict
your diet depends on the way
the syndrome affects you. If you
feel that certain foods cause the

                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
Name of the medicinal product
Colotal tablets 135 mg
2.
Qualitative and quantitative composition
One coated tablet contains 135 mg mebeverine hydrochloride.
Each tablet Duspatal 135 mg contains 79 mg sucrose and 97 mg lactose
monohydrate.
For the full list of excipients see section 6.1
3.
Pharmaceutical form
coated tablets.
4.
Clinical particulars
4.1
Therapeutic indications
Irritable bowel syndrome and conditions included in this group such
as:
chronic irritable colon, gastro-intestinal spasm secondary to organic
diseases
_ _
4.2
Posology and method of administration
_Adults _
Colotal tablets should be swallowed with a sufficient amount of water
(at least
100 ml water). Do not chew.
One 135 mg tablet three times daily; to be given approx. 20 minutes
before
meals.
_ _
_Paediatric Population _
Colotal 135 mg tablets are not recommended for use in children and
adolescents
below 18, due to insufficient data on safety and efficacy.
4.3
Contra-indications
Hypersensitivity to the active substance or to any of the excipients
(see
section 6.1).
4.4
Special warnings and precautions for use
Since Colotal tablets 135 mg contain lactose, patients with rare
hereditary
problems of galactose intolerance, the Lapp lactase deficiency or
glucose-
galactose malabsorption should not take this medicine.
Since Colotal tablets 135 mg contain sucrose, patients with rare
hereditary
problems of fructose intolerance, glucose-galactose malabsorption or
sucrase-isomaltase insufficiency should not take this medicine.
4.5
Interactions with other medicaments and other forms of
interaction
No interactions of mebeverine are known.
4.6
Fertility, pregnancy and lactation
_Pregnancy _
There are no or limited amount of data from the use of mebeverine in
pregnant women.
Animal studies are insufficient with respect to reproductive toxicity
(see
section 5.3). Colotal is not recommended during pregnancy.
_Lactation _
It is unknown whether mebeverine or its metaboliltes are excreted in
human
milk. The excretion of meb
                                
                                Read the complete document